Standardisation of Factor VIII and von Willebrand Factor in plasma: Calibration of the 4th International Standard (97/586)

Thrombosis and Haemostasis

Volumn 85, Issue 4, 2001, Pages 634-638

  Hubbard, A R ^a   Rigsby, P ^a   Barrowcliffe, T W ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Blood plasma; Factor VIII; International Standard; Von Willebrand factor

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 8; COLLAGEN; RISTOCETIN; VON WILLEBRAND FACTOR;

ARTICLE; ASSAY; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CALIBRATION; COLLAGEN METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; STANDARDIZATION; STATISTICAL ANALYSIS; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE;

EID: 0035073745     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615645     Document Type: Article

References (11)

1. The provision of standards for blood coagulation factors
2. Standardization of Factor VIII-III. Establishment of a stable reference plasma for Factor VIII-related activities
3. Standardisation of Factor VIII-V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand Factor activities in plasma
4. International biological standards and reference preparations. 1. Preparation and presentation of materials to serve as standards and reference preparations
5. Geometric means and measures of dispersion
6. Design and analysis of accelerated degradation tests for the stability of biological standards II. A flexible computer program for data analysis
7. Immunologic studies of Factor VIII coagulant activity 1. Assays based on a hemophilic and an acquired antibody to VIII:C
8. Retention of coagulation factors in plasma frozen after extended holding at 1-6° C
9. An ELISA test for the binding of von Willebrand antigen to collagen
10. Collagen binding assay for von Willebrand Factor (VWF:CBA): Detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source